G Prasad - Dr Reddys Chairman

<div class='circular--portrait' style='background:#754DEB;color: white;font-size:4em;padding-top: 15px;;'>DR</div>
RDY -- USA Stock  

USD 42.35  0.23  0.54%

  Chairman
Mr. G. V. Prasad serves as a CoChairman of the Board, Chief Executive Officer, Managing Director of the Company. Mr. G V Prasad leads the core team at Dr. Reddys that has contributed signifi cantly to its transformation from a midsized domestic operation into a global pharmaceutical major. He is the architect of Dr. Reddys successful Global Generics and Active Pharmaceutical Ingredient strategies, as well as the companys foray into biosimilars and diff erentiated formulations. Mr. Prasad is engaged with strengthening the companys research and development capabilities, supporting progressive people practices and building a holistic culture of operational excellence. He was listed in the prestigious Medicine Maker 2018 Power List of most inspirational professionals shaping the future of drug development, and one of Indias Greatest 50 CEOs Ever by Outlookmagazine in 2017
Age: 56  Chairman Since 2014      
91 40 4900 2900  http://www.drreddys.com
Prasad holds a degree in Chemical Engineering from the Illinois Institute of Technology, Chicago, USA and a Masters in Industrial Administration from Purdue University, USA.q

Management Efficiency

The company has Return on Asset of 6.98 % which means that on every $100 spent on asset it made $6.98 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 18.75 % implying that it generated $18.75 on every 100 dollars invested.
The company has 811.73 M in debt with debt to equity (D/E) ratio of 20.5 . This implies that the company may be unable to create cash to meet all of its financial commitments. Dr Reddys Laboratories has Current Ratio of 1.92 which is typical for the industry and considered as normal.

Similar Executives

Found 8 records

CHAIRMAN Since

Jeffrey LeidenVertex Pharmaceuticals Incorpor
2012
Roy VagelosRegeneron Pharmaceuticals
1995
Yasheng YangOrigin Agritech Limited
2010
Gengchen HanOrigin Agritech Limited
2016
Marry BrlasPerrigo Company Plc
2016
Joshua BogerVertex Pharmaceuticals Incorpor
2009
Joseph PapaPerrigo Company Plc
2015
Michael McCallisterZoetis
2015

Entity Summary

Reddys Laboratories Limited operates as an integrated pharmaceutical company worldwide. Reddys Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India. Dr Reddys operates under Drug ManufacturersSpecialty Generic classification in USA and is traded on BATS Exchange. It employs 21966 people.Dr Reddys Laboratories Ltd (RDY) is traded on BATS Exchange in USA and employs 21,966 people.

Dr Reddys Laboratories Leadership Team

G Prasad, Co-Chairman of the Board, Chief Executive Officer, Managing Director
MARC KIKUCHI, Chief Executive Officer, North America Generics
Hans Hasler, Additional Independent Director
Leo Puri, Non-Executive Independent Director
Sandeep Poddar, Compliance Officer, Company Secretary
Satish Reddy, Co-Chairman of the Board
Kedar Upadhye, IR Contact Officer
Samiran Das, Executive Vice President Head - FTO and GGPM
Sauri Gudlavalleti, Global Head of Integrated Product Development Organization
YUGANDHAR PUVVALA, Global Head of Supply Chain
Amit Biswas, Executive Vice President - Integrated Product Development
Ravi Bhoothalingam, Non-Executive Independent Director
Alok Sonig, Senior Vice President & India Business Head (Generics)
Allan Oberman, Non-Executive Independent Director
J Ramachandran, Executive Vice President-Management Systems and Corporate Initiatives
Prasad Menon, Lead Non-Executive Independent Director
K Rao, Sr. Vice President & Head ? Chemical Technical Operations (CTO)
Abhijit Mukherjee, COO
Anil Namboodiripad, Global Head of Proprietary Products
Saumen Chakraborty, President, Chief Financial Officer and Global Head of ITBPE, Legal & Compliance and FMCRE
SANJAY SHARMA, Global Head of Manufacturing
Shikha Sharma, Non-Executive Independent Director
Sridar Iyengar, Non-Executive Independent Director
Ganadhish Kamat, Executive Vice President and Global Head-Quality
Sripada Chandrasekhar, President, Global Head of HR and Member of Management Council
Omkar Goswami, Non-Executive Independent Director
Erez Israeli, Chief Operating Officer and Global Head of Generics & PSAI
Kalpana Morparia, Non-Executive Independent Director
Bharat Doshi, Non-Executive Independent Director
J Moreau, Non-Executive Independent Director
Raymond Vre, Global Head of Biologics
Raghav Chari, Senior Vice President - Proprietary Products
Bruce Carter, Non-Executive Independent Director
Saunak Savla, IR Contact Officer
Ashok Ganguly, Non-Executive Independent Director
Umang Vohra, Executive Vice President Head - North America Generics
M Ramana, Chief Executive Officer, Branded Markets (India and Emerging Markets)
Cartikeya Reddy, Senior Vice President Head - Biologics
Anupam Puri, Non-Executive Independent Director
Archana Bhaskar, Chief Human Resource Officer
Deepak Sapra, Global Head of PSAI

Stock Performance Indicators

Did you try this?

Run Efficient Frontier Now

   

Efficient Frontier

Plot and analyze your portfolio and positions against risk-return landscape of the market.
All  Next Launch Module

Currently Active Assets on Macroaxis

C   
Purchased over 30 shares of
few hours ago
Traded for 80.1
F   
Purchased over 300 shares of
few hours ago
Traded for 9.16
CRSP   
Purchased over 50 shares of
few hours ago
Traded for 58.39
GM   
Purchased over 70 shares of
few hours ago
Traded for 34.91
S   
Purchased over 500 shares of
few hours ago
Traded for 5.02
Additionally take a look at Your Equity Center. Please also try Companies Directory module to evaluate performance of over 100,000 stocks, funds, and etfs against different fundamentals.